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Abstract
Parasitic infections are the major threat prevalent in tropical and subtropical 
regions throughout the world. Different parasitic infections take a huge toll on 
mortality and morbidity at global level. Different parasites invade the host sys-
tem, multiply inside host cells of their choice and sabotage defense mechanisms 
to overpower the host. T-cell immunity is majorly affected in different parasitic 
diseases such that the peripheral T-cell immune response is altered along with 
lesser explored thymic changes. Direct and/or indirect effect of parasitic infection 
leads to alterations in T-cell development, differentiation and activation resulting 
in deregulated T-cell immune mechanisms. Cytokines of interferon family play a 
significant role in determining the disease outcome and severity. Therefore, in this 
chapter, we here provide a detailed overview of the functional role played by IFNs 
during parasitic diseases in terms of their influence on peripheral T-cell activation 
and tolerance along with lesser explored impact on developing T cells in the thymus 
with altered microenvironmental niches.
Keywords: parasitic diseases, periphery, IFN, T cells, thymus, immunomodulation, 
disease outcome
1. Introduction
Parasitism is a relationship among species, in which one organism, the para-
site, sustains on the host organism. Parasitic diseases can affect almost all living 
organisms. Parasites are dependent on the host organisms for their own survival. 
Not all parasites are harmful but some cause severe pathology to the host, such as 
Leishmania, Plasmodium, Trypanosoma, etc. Parasites known to affect humans are 
divided into three classes: protozoans, helminths and ectoparasites [1]. Parasite 
invasion triggers the innate, inflammatory and adaptive immune responses inside 
the mammalian host. Innate immunity recognizes the non-self and activates 
the T-cell–mediated adaptive immune system in order to eliminate the invader. 
Removal or recruitment of parasite is dependent on the production of distinct 
pattern of cytokines from specific T cells. T cells are formed through an intricate 
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developmental process with the dynamic stage-specific changes in the developing 
lymphocytes. T-cell development takes place in multiple steps originating from 
bone marrow to progenitors of T cell maturation in the thymus. It has been known 
that “thymus” plays the main role in the production of a self-tolerant adaptive 
immune response that is critical against the pathogen’s threat [2]. A variety of 
infectious agents like protozoans mainly Trypanosoma spp., Plasmodium spp. and 
Leishmania spp. alter thymic structure and function. Thymic atrophy reflected by 
lymphocyte depletion is considered as a common feature in response to pathogens 
but the consequences on thymic function may differ significantly in different 
infections. Together with structural and functional changes induced by the parasite 
in the thymic microenvironmental niches, the development of thymocytes and thus 
the altered thymic output have direct implications in peripheral T-cell response. 
T-cell–based immune responses are further modulated via different types of 
cytokines viz. interferons (IFNs), tumor necrosis factors (TNFs) and interleukins 
(ILs) with implication in the disease outcome and progression. Different cytokines 
work independently or in collaboration as determinants of the disease establish-
ment and progression. Host peripheral immune response influencing the disease 
outcome during parasitic infection is substantially studied in vitro on cell lines, 
in vivo in experimental models and in human subjects. A heterogeneous T-cell 
response marks the disease pathogenesis. A Th1 cell-mediated immune response is 
predominated by pro-inflammatory cytokines such as IFN-γ and TNF-α and plays 
a key role in arresting the disease by limiting the parasite replication. Contrary to 
this, a shift toward Th2 immune response, represented by increased expression 
of the anti-inflammatory IL-4, is associated with exacerbation of infection and 
uncontrolled parasite replication. This response is due to suppressive effects of Th2 
cytokines on Th1 immunity. The important role played by the crucial IFN family of 
cytokines during parasitic diseases is emphasized in peripheral circulation as well 
as with regard to thymus-centric modulation of T-cell–based immunity in different 
infectious diseases.
2. A brief note on interferons
IFNs are the key soluble immune molecules belonging to the IFN family with 
specific structural and functional characteristics. They are divided into three main 
groups based on the structural details and functional contribution toward modulat-
ing the immune response during parasitic infections: IFN-I, II and III. The IFN-I 
family includes IFN-α and IFN-β. IFN-I signaling is mediated through a common 
cell surface receptor, (IFNAR). IFN-I production by a wide variety of cells mediates 
autocrine and paracrine signaling pathways upon viral infections. The IFN-II family 
represents IFN-γ. Its response is mediated by IFN-γ receptor (IFNGR). IFN-II plays 
a role in defense against intracellular pathogens by modulating diverse cellular 
functions. The third IFN-III family, or IFN-λ, comprises four different subtypes: 
IFN-λ1, λ2, λ3 and λ4. IFN-III is not well studied but has a role similar to IFN-I. The 
expression of IFN-λR receptor is mainly restricted to cells of epithelial origin [3].
3. Protozoan diseases
Protozoan parasitic infections are among the most common life-threatening 
infectious diseases. They can enter into the human body generally by a bite from 
an insect vector or through fecal-oral route. Protozoan parasites are responsible 
for serious infections. Plasmodium falciparum (P. falciparum), Toxoplasma gondii 
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(T. gondii), Leishmania donovani (L. donovani), Trypanosoma cruzi (T. cruzi), 
Trypanosoma brucei (T. brucei) and Giardia intestinalis (G. intestinalis) are among 
the most common protozoan pathogenic parasites and cause malaria, toxoplasmo-
sis, leishmaniasis, Chagas disease, sleeping sickness and giardiasis, respectively. The 
three pathogenic parasitic diseases viz. Chagas disease caused by T. cruzi, malaria 
caused by Plasmodium spp. and leishmaniasis caused by Leishmania spp. will be 
discussed in length in relation to discrete T-cell–associated quantitative and qualita-
tive alterations, reported in all these protozoan diseases. Disease-specific cytokine 
milieu with distinct role of IFNs is implicated in modulating disease progression 
and outcome. A snapshot of IFN-associated T-cell immune modulation in context to 
each of the protozoan disease is discussed in subsequent sections.
4. Chagas disease caused by T. cruzi
Chagas disease or American trypanosomiasis is caused by the parasite T. cruzi, 
transmitted to mammals by insect vectors. It is a hemoflagellate protozoan belong-
ing to the kingdom Protista, phylum euglenozoa and class Zoomastigophora. It is 
a multi-host parasite transmitted by insect triatomines and is also called as “assas-
sin bug” or “kissing bug.” It is common in parts of Mexico and Central and South 
America [4].
4.1 Disease transmission
Transmission of T. cruzi parasite to humans is understood based on the route of 
infection as primary or secondary. The primary route is the most frequent route, 
and infection occurs through insect bite, blood transfusion or congenital and oral 
route. The secondary route is less frequent such as accidental infection during ani-
mal handling or infected organ transplant. The most common transmission route 
in the Brazilian region is oral transmission and the second is through contaminated 
food/beverage, whereas in Argentina, Bolivia, Colombia, Ecuador, French Guinea 
and Venezuela, contaminated food consumption is the main reason of infection [4].
4.2 Disease severity and diagnosis
Chagas disease has two phases of infection: an acute and a chronic phase. Acute 
form is mild. The parasite remains in the blood circulation for a long time (few 
weeks to months). Acute phase is followed by prolonged asymptomatic “chronic 
phase,” marked by very few or negligible parasite in blood. Chronic Chagas disease 
symptoms include dilated colon or esophagus and different heart rhythm abnor-
malities. Diagnosis of acute phase of infection is marked by the presence of parasite 
in peripheral blood circulation and can be observed by microscopic examination 
of stained blood smear. Diagnosis of chronic Chagas disease is generally made by 
testing blood for parasite-specific antibodies [4].
4.3 Peripheral T-cell response in T. cruzi infection
Chagas disease is associated with several immunological alterations due to 
change in the expression pattern of cytokines that play a fundamental role in 
regulating the functionality of almost all cell types. T. cruzi infection triggers 
the nitric oxide (NO) production and may exert protective or toxic effects on 
the host immune system. NO can induce oxidative stress via damaging the host 
tissues. Inducible NO synthase pathway gets activated upon parasitic invasion, 
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produces NO and is highly responsible for macrophage-mediated intracellular 
T. cruzi elimination within infected cells. The cytokines such as IFN-γ, TNF-α 
and chemokines are produced in large amounts during T. cruzi acute infection 
and are potent inducers of NOS [5]. Along with NO synthase (NOS), several 
potent effector mechanisms such as T-cell–mediated immunity involving both 
CD4+ and CD8+ T-cell compartments are essentially involved in defense against 
T. cruzi invasion and replication in mammalian host. Relevance of T cells is well 
documented in experimental T. cruzi mice model where mice lacking T-cell 
subsets develop disease with high parasite load in tissues and periphery [6, 7]. 
These findings support the important role of T-cell populations in dealing with 
acute and chronic phase of T. cruzi infection in humans. Double positive (DP) 
CD4+CD8+ T-cell population was found to be increased in number with increased 
expression of activation markers (CD38 and HLA-DR) during chronic Chagas 
disease demonstrating that these DP T cells contribute to immune response 
against T. cruzi infection [8]. Cardiac inflammatory infiltrate of DP T cells in 
patients who have undergone cardiac transplant suggests that their performance 
in controlling the cardiac disease in humans is worth considering [8].
4.4 IFN-I–associated immune changes in T. cruzi infection
IFN-I has an important role in inhibiting the parasite multiplication. Induction/
production of IFN-I in response to T. cruzi is stage specific [9] and primarily 
dependent on the dose/amount of parasite, and route of infection. Exogenous IFN-I 
treatment in T. cruzi–infected mice showed that mice develop increased resistance 
to infection by stimulating natural killer and T-cell activities [10]. Protective action 
of IFN-I associated with LRG-47 [IFN-inducible p47GTPase] is well documented 
in experimental mice models. LRG-47 regulates host resistance against intracellular 
pathogens in a comparative study with wild-type (WT) and knockout (KO) mice, 
where LRG-47 KO mice exhibit severe anemia, thrombocytopenia and atrophy of 
thymus, in contrast to WT counterparts. Similar to in vivo model, IFN-I–induced 
in vitro stimulation of LRG-47 KO macrophages also display a defect in intracel-
lular killing of amastigotes [11]. IFN-I is reported to play a dual role during disease: 
protection from disease and establishing pathology. Disease-exacerbating role of 
IFN-I has been reported in WT and IFNAR−/− mice model such that IFNAR−/− mice 
were able to restrict the parasite growth and survive, while the WT mice failed to 
resist the infection [12]. It suggests that under the conditions of increased parasite 
load, IFN-I contributes to the pathogenesis of infection [12].
4.5 IFN-II (IFN-γ)–associated immune changes in T. cruzi infection
IFN-γ has a central role in Chagas disease cardiomyopathy. The disease is char-
acterized by increased production of IFN-γ in the periphery [13]. Several cytokines, 
including IFN-γ, IL-1-α, IL-6 and TNF-α, modulate the expression of immune cells 
and contribute to the inflammatory process by recruiting the T cells into the inflam-
matory sites. Conversely, IL-4, TGF-β and IL-10 negatively regulate NO production 
and downregulate the intracellular control of T. cruzi infection by IFN-γ–activated 
macrophages [14]. In humans, IFN-γ was detected as a predominant cytokine in 
circulation during T. cruzi infection [15]. IFN-γ regulates the expression of several 
genes, transcription factors, inflammatory cytokines such as TNF-α, chemokines, 
and other pathogen-resistance genes including inducible nitric oxide synthase 2 
(iNOS or NOS2) [16]. Higher amount of IFN-γ along with TNF-α leads to an effi-
cient parasite killing and enhanced function of memory T cells [17]. It is evident 
from the fact that mice deficient in IL-12 that is necessary for IFN-γ production 
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exhibit severe tissue and systemic parasitism suggesting the importance of the 
IFN-γ in controlling intracellular parasitism [18]. It is known that T-cell–mediated 
control of the disease is dependent on the duration of infection and tissue damage. 
The detection of IFN-γ and TNF-α during early phase of chronic T. cruzi infection is 
associated with IL-10 production by CD4+ T cells [17]. IFN-γ production is higher in 
chronic Chagas cardiomyopathy compared to asymptomatic patients, wherein IL-10 
is reported to be highly expressed [16]. IL-10 has a counter effect on Th1 responses 
via downmodulating IFN-γ response, which, if sustained for long time, may have 
harmful effects on the host [19]. Altered cytokine profile either quantitatively or 
qualitatively can be a major cause of chronic Chagas disease. IFN-γ is well known as 
a protective lymphokine against T. cruzi, but there are many reports stating the dual 
role (antiparasitic, protective and pathogenic) of IFN-γ in Chagas disease [13, 14]. 
Several reports suggest myocarditis and heart failure in patients with Chagas disease, 
possibly due to continuous production of IFN-γ by T cells [16]. IFN-γ controls 
infection through NOS production and activating ROS through induction of NADP 
oxidases, while resistance of T. cruzi to ROS induces serious alterations in heart func-
tion. The detrimental role of overexpression of IFN-γ has been proven in experiment 
with transgenic mice, where it results in TNF-α–dependent murine myocarditis and 
cardiomyopathy [20].
4.6 IFN-III–associated immune changes in T. cruzi infection
Type III IFNs serve as regulatory cytokines by reducing the damage caused by 
pro-inflammatory cytokines or by retaining the more potent IFN-I for times when 
immune responses are inadequate [21]. This subtype is poorly recognized and has 
not been studied in Chagas disease.
4.7 Thymic alterations in T. cruzi infection
Circulation of T cells in response to parasitic infection is securely controlled 
as various cytokines and chemokines influence the disease outcome. It has been 
reported that in T. cruzi infection, both Th1 and Th2 cytokines are associated with 
resistance and susceptibility to disease, respectively. Influence of cytokines on 
thymus function is not much studied. Pérez et al. [22] made a detailed evaluation 
of the effect of pro-inflammatory (IFN-γ, IL-12 and iNOS) and anti-inflammatory 
cytokines (IL-4 and IL-10) on thymus in a study with experimental C57BL/6 
murine model. Uninfected knock out mice for both pro-inflammatory and 
anti-inflammatory cytokines showed thymocyte cellularity similar to wild-type 
mice, although apoptotic loss of DP thymocytes was seen in infected mice group, 
showing that thymic atrophy is independent of IFN-γ or iNOS [22]. However, in 
another study, it is shown that upon T. cruzi infection in C57BL/6 mice, IL-10 and 
IFN-γ play a role in controlling thymic T-cell activation via altering the thymic cell 
function, but the extent of immunological disturbances was not clearly described 
[23]. In experimental Chagas disease, it was observed that the increased level of 
extracellular matrix (ECM) in thymus favors the export of immature thymocytes 
from thymus. Increased migration of thymocytes in response to fibronectin leads 
to a high number of DP T cells’ migration from the thymus to peripheral lymphoid 
organs. The frequency of peripheral CD4+CD8+ DP T cells is increased in acute 
T. cruzi infection up to 16 times in subcutaneous lymph nodes [24, 25]. Thymic 
atrophy is an acute phenomenon observed in the infected mice, accompanied 
by alteration in the thymic structure. The mechanism is understood in terms of 
hormonal dysregulation induced under infection condition. The production of pro-
inflammatory cytokines, IL-1, IL-6 and TNF-α increases during the infection and 
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activates the HPA axis causing the release of glucocorticoids (GCs) [26]. GCs are 
steroidal hormones that lead to thymus atrophy with depletion of immature cortical 
thymocytes. Thymocyte depletion is seen to be directly proportional to increased 
TNF-α levels. However, this depletion is attributed to TNF-induced glucocorticoids 
rather than TNF-α directly such that it is not the cytokines, but the downstream 
molecules induced by them that lead to the observed thymic changes [27, 28]. It 
has been reported that during T. cruzi infection, prolactin (PRL) has a significant 
role in homeostatic balance of thymic corticosterone [29, 30]. Under stressful 
conditions, PRL balances the negative effects of GC by increasing thymocytes and 
thymic epithelial cell (TEC) proliferation. PRL rescues these cells from apoptosis in 
opposition to GC, which inhibits thymocyte growth. Recent reports show that PRL 
secretion is also altered along with GC secretion with decreased level of PRL paral-
leling increased GC levels during acute T. cruzi infection, causing an imbalanced 
cross talk that may correlate with the thymic involution [31, 32]. Thus, it can be said 
that GC and PRL are responsible for the loss of thymocytes, which leads to thymic 
atrophy. Thus, a dysregulated immuno-endocrine axis leads to profound effects on 
the thymus and disease outcome during T. cruzi infection. Peripheral and thymic 
changes associated with Trypanosoma infection are depicted in Figure 1.
5. Malaria caused by Plasmodium spp.
Malaria is a deadly disease caused by Plasmodium parasite belonging to the 
family Plasmodiidae. The disease is transmitted to humans by the bite of infected 
female Anopheles mosquito. Parasite species P. falciparum and P. vivax cause 
malaria in humans. Based on WHO reports, malaria is prevalent in 87 countries 
Figure 1. 
Peripheral and thymic changes induced in host organism (mice and/or human) upon T. cruzi infection.
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throughout the world, with estimated 219 million cases and 435,000 estimated 
death reports [33]. An estimated 91% of all deaths due to malaria occur in Africa.
5.1 Disease transmission
Malaria is generally transmitted through the bite of Anopheles mosquitoes with 
high activity between dusk and dawn. Disease transmission is dependent on factors 
such as climatic conditions comprising rainfall patterns, temperature and humidity, 
host immunity, parasite species and the vector involved [33].
5.2 Disease severity and diagnosis
Malaria can be fatal if not treated. Disease outcome is determined by the parasite 
species and host immunity. Complications may arise in the form of cerebral malaria 
(CM) wherein the parasite infects the brain and leads to serious damage including 
seizures and coma accompanied with breathing problems, organ failure and low 
blood sugar. Early detection and disease treatment are important to reduce the 
risk of disease severity. Staining-based microscopic parasite diagnosis methods or 
malaria rapid diagnostic tests (RDTs) are widely used for preliminary diagnosis of 
the disease. RDTs detect specific antigen produced by malaria parasite in human 
blood using a dye-labeled capture antibodies providing an evidence of malaria 
infection [33].
5.3 Peripheral T-cell immune response associated with Plasmodium infection
Host immune response against Plasmodium parasites in vitro and in vivo is 
well studied in murine models (P. yoelii, P. vinckei, P. chabaudi and P. berghei) and 
humans (P. malariae, P. vivax, P. falciparum, P. ovale and P. knowlesi) [3]. The 
parasite stimulates multifaceted immune responses, including antibodies, NK and 
NKT cells, CD4+ and CD8+ T cells [34]. T cells play a major role in protection against 
Plasmodium. Both Th1 and Th2 subsets of CD4+ T cells are the major players to 
control the systemic infections [35]. CD4+ T cells stimulate CD8+ T-cell cytotoxic 
activity, inhibit the development of liver stages and prevent the infection of red 
blood cells [36]. Thus, a balance between the cytokines and other immune mol-
ecules produced by different cell types is critical in determining the outcome of the 
infection.
5.4 IFN-I–associated immune changes in Plasmodium infection
IFN-γ is the most widely studied in malaria and has a versatile effect on the 
host. It may exert a protective or destructive effect, depending on the stage of the 
infection or the species of Plasmodium involved. Disease-protective phenomenon 
was observed in mice infected with P. berghei, where post-IFN-β treatment sur-
vival of mice is prolonged compared to non-treated counterparts [37]. Protection 
to disease is driven by a sensory mechanism against Plasmodium in the liver that 
mediates a functional antiparasite response driven by type I IFN. IFN-Ι is known 
to be active during the late phase of the liver stage infection. It is evident by the 
fact that treatment of P. yoelii–infected mice with recombinant IFN-α does not alter 
the hepatic parasite burden. This results in partially limiting the parasite growth 
in the liver and influences the commencement of erythrocytic stage infection. 
Leukocytes are recruited around the liver-stage of the parasite leading to reduced 
parasitemia [38]. Blood transcriptional profile of mild and severe malaria infection 
cases revealed that a specific set of genes was significantly associated with a mild 
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form as compared to their expression pattern in severe form of malaria. Studies on 
malaria-infected individuals from Malawi region revealed that genes responsible 
for IFN-I signaling pathway have an important role in the development of protec-
tive immune response against malaria. This is proved by molecular studies wherein 
mutations within IFN-α receptor (IFN-αR) lead to disease susceptibility and 
severe disease in Malawian population [39]. In contrast to the protective effects 
discussed above, a pathogenic role for IFN-I in Plasmodium infections has also 
been described. This has been reported in murine models, where the absence of 
IFN-I signaling in P. berghei–infected mice led to reduced parasite load and resis-
tance against CM. The development of CM occurs as a result of detrimental brain 
injuries due to damaging inflammatory host immune response [40, 41]. Expression 
analysis of CD4+ T cells from P. berghei ANKA (PbA)-infected mice revealed that 
CD4+ cells showed dominance of IFN-I and IFN-γ signaling pathway-related genes. 
Mice deficient in IFN-I signaling had reduced parasite burden and displayed no 
CM-related symptoms. IFN-I suppressed IFN-γ production via inhibiting CD4+ 
T-bet+ T-cell derived IFN-γ production and hampered protective Th1-mediated 
control of parasitemia in P. chabaudi–infected mice [41]. Progression to CM can be 
modified by host genetic factors. A robust association between IFNAR1 and CM 
protection is well documented in experimental CM in IFNAR1−/− mice infected 
with P. berghei [40]. It is reported that splenic CD8+ T cells from IFNAR1−/− mice 
got activated functionally but were unable to mediate any damage to brain tissue 
and cause CM development. This proves that IFNAR1 signaling promotes CD8+ 
effector activity, which is mandatory for CM, in both humans and mouse [40]. 
There are controversial reports stating the IFN-I–mediated suppression on IFN-γ 
activity. During early stage of P. chabaudi infection, IFN-I induced by the infection 
plays a disease-exacerbating role by suppressing IFN-γ producing CD4+ T cells in 
C57BL/6 mice [41]; however, in 129 Sv/Ev mice, IFN-I has minor roles in control-
ling the disease pathology [42]. Similar instance is observed in humans where 
polymorphism in human gene encoding for IFNARI strongly supports protection 
from the disease [43]. These controversial reports suggest that duration of activity 
and levels of IFN-I are important in regulating immune response against parasite 
growth [3].
5.5 IFN-II (IFN-γ)–associated immune changes in Plasmodium infection
IFN-γ regulates various components of the host immune system such as 
defense against intracellular pathogens by antigen presentation, antimicrobial 
mechanism, leukocyte development and immune cell trafficking. The protective 
role of IFN-γ is evident from the in vitro and in vivo studies, where inhibitory 
effect of IFN-γ on parasite multiplication was observed in P. berghei sporozoites-
infected murine hepatocytes and/or human hepatic HEPG2 cells upon treatment 
with human recombinant IFN-γ [44–47]. IFN-γ helps in controlling the parasitism 
by activating macrophages and promoting phagocytosis of circulating parasites 
and plays a crucial protective role during blood-stage infection. P. chabaudi 
AS-infected mice treated with monoclonal antibody against IFN-γ had less control 
of parasite multiplication, suggesting that IFN-γ is essential for limiting parasite 
multiplication. Similar effects were evident in P. chabaudi AS-infected mice that 
were lacking IFN-γ receptor. These mice had lower survival rates as compared 
to the WT controls [48]. This suggests that IFN-γ production at different stages 
during infection could alter parasite survival and hence disease outcome. In P. 
berghei infection, IFN-γ along with TNF-α also plays a protective role by parasite 
removal activity [49]. The natural resistance to Plasmodium infection is reported 
in humans from tribes in Mali where resistance was correlated with increased 
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levels of IFN-γ [50], suggesting a protective role for IFN-γ against malaria. IFN-γ 
is essential in both protective immunity and pathogenesis of the diseases. During 
malaria infection, elevated levels of IgE antibodies are also observed. IgE contain-
ing immune complexes are pathogenic and not protective as they are involved in 
overproduction of TNF-α. TNF-α acts as a major pathogenic factor in malaria and 
poses an increased risk of severe disease or death due to P. falciparum infection 
[35]. IFN-γ promotes migration of leukocytes and pathogenic CD8+ T cells to 
the brain during infection induced by P. berghei ANKA in WT 129P2Sv/Ev mice 
compared to IFN-γ R1-deficient mice. The production of elevated levels of IFN-γ 
during parasite blood-stage is associated with susceptibility to severe CM malaria 
[51]. Its protective or harmful effect on the host depends on the stage of infection 
and target organ [44].
5.6 IFN-III–associated immune changes in Plasmodium infection
Type I and type II interferons [IFNs] are critical to govern the disease outcome; 
however, reports on the involvement of recently identified IFN-III humans during 
malaria infection are scarce [3].
5.7 Thymic alterations in Plasmodium infection
Malarial infection results in increased levels of IFN-γ and TNF-α in human 
serum. Both these cytokines have been shown to be involved in double positive 
T-cell death [52–54]. However, neutralizing the effect of IFN-γ and TNF-α did 
not alter the apoptosis-inducing capacity of the serum [28]. Conversely, TNF-α 
neutralization helps in the reduction of DP T-cell count due to increased apoptosis, 
stating that TNF-α exerts a protective rather than a destructive role in malaria-
induced thymic atrophy [28]. Studies done on BALB/c mice model show a high level 
of apoptosis and premature migration of thymocytes in mice upon Plasmodium 
infection along with overexpression of TNF-α associated with thymic atrophy 
[55, 56]. Reports on direct effect of IFN family on thymic changes during malaria 
Figure 2. 
Peripheral and thymic changes induced in host organism (mice or human) upon Plasmodium infection.
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infection are scarce. In P. berghei–infected mice, changes in the thymic microenvi-
ronment alter the thymocytes’ migration pattern with the direct implication in the 
export of immature cells to the periphery [57]. It is modeled that in Plasmodium-
infected mice, the number of CD4+ T cells decreases due to the destruction or 
reduced production of CD4+ T cells and the number of CD8+ T cells increases due 
to peripheral expansion or redistribution of preexisting cytotoxic T cells or due to 
an increase in thymic output [58]. Thymus atrophy seen in Plasmodium infection is 
accompanied by alterations in thymus architecture with loss of cortical-medullar 
delimitation [56]. The atrophy of thymus starts with an early stage of infection and 
the thymus weight is reduced markedly [59]. Plasmodium infection interferes with 
the positive and negative selection process of thymocytes resulting in apoptosis of 
thymocytes and thymic atrophy. This is evident from P. chabaudi non-lethal malaria 
model where thymic atrophy is reported to occur due to depletion of single positive 
CD4+ and CD8+ T cells [56, 60]. Changes in the thymic microenvironment, altered 
expression of the ECM proteins and chemokines observed in P. berghei–infected 
mice result in an altered intrathymic thymocyte migration pattern and defective 
thymocyte development [57]. Thus, a dysregulation in thymic immune cross talk 
comprising IFNs results in thymic structural and functional changes as depicted in 
Figure 2.
6. Leishmaniasis caused by Leishmania spp.
Leishmania is a tropical protozoan parasite belonging to the family 
Trypanosomatidae. The parasite is transmitted by the bite of the female phleboto-
mine fly species in old world countries and by Lutzomyia species in new world 
countries. More than 20 Leishmania species are known to circulate in endemic foci 
in Africa, Asia, the Middle East, the Mediterranean region, Central-South America, 
and southern Europe. The L. donovani and L. infantum/chagasi complex is respon-
sible for VL; the L. major, L. tropica, L. aethiopica and L. mexicana complex causes 
CL; and the subgenus L. Viannia complex causes CL and MCL as per the classical 
association of specific parasite species with distinct clinical outcomes. The disease 
has a wide geographical occurrence covering 97 countries and territories with 
endemic foci for each of the different clinical manifestations [61].
6.1 Disease transmission
Female phlebotomine sandflies transmit the Leishmania parasite during blood 
meal. Disease transmission is dependent on the parasite or sandfly species, environ-
mental conditions, host immunity and animal reservoir [62].
6.2 Disease severity and diagnosis
There are three main clinical forms of leishmaniasis: Visceral leishmaniasis 
(VL) or kala-azar is characterized by hepatosplenomegaly, fever and anemia. 
Cutaneous leishmaniasis (CL) is the most common form of the disease, character-
ized by skin lesions on exposed body parts, scars on the body and societal stigma. 
Mucocutaneous leishmaniasis (MCL) manifestation involves mucous membranes of 
the nose, mouth and throat. Diagnosis is generally based on microscopic examina-
tions of Leishmania amastigotes in skin lesions in case of CL and rapid diagnostic 
recombinant K39 tests in case of VL with recent complementation with parasite-
specific molecular diagnostics [62–64].
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6.3 Peripheral T-cell response associated with Leishmania infection
There is a mixed Th1 and Th2 immune response during Leishmania infec-
tion with discrete quantitative and qualitative changes in T-cell subsets and the 
associated cytokines. Numerous reports explain counter-regulatory effects of 
T-cell subset–specific cytokines both at transcriptional and at translational levels. 
Leishmania-infected host exhibits a dynamic peripheral Th1/Th2 immune environ-
ment such that Th1 immune-activation is associated with IL-2, IFN-γ and TNF-α, 
which leads to macrophage activation and disease resolution, while Th2 response 
is associated with IL-4, IL-5 and IL-13 that supports disease progression [65]. Treg 
cells that produce IL-4 and IL-10 cytokines are also involved in regulating Th2/Th1 
balance toward disease outcome. In mice infected with L. donovani, CD4+ T cells 
are activated on the first day of infection and proliferate several folds resulting in 
splenomegaly [66]. CD8+ T cells also produce cytokines and chemokines, which 
enhance immunity to pathogens [67]. So along with CD4+ T-cell response, CD8+ 
T cells also provide a level of control through production of IFN-γ and contribute 
to disease outcome. In contrast to protection mechanism, CD8+ T cells induce 
cytotoxicity in L. braziliensis infection [68]. Thus, in the acute phase of Leishmania 
infection, CD8+ T cells are protective because they produce IFN-γ, while in the 
chronic phase, they promote pathology because of cytotoxicity. In L. infantum-
infected murine model, alterations in the number of peripheral CD4+ and CD8+ 
T cells are observed, wherein increase in peripheral CD8+ T cells is responsible for 
the control of L. infantum infection with a slight decrease in the number of CD4+ T 
cells [69].
6.4 IFN-I–associated immune changes in Leishmania infection
IFN-II is considered the main player in cell-mediated immune responses against 
infections, but recently, IFN-I is also being reported to play a role in Leishmaniasis 
pathology outcome. Activated macrophages initiate the parasite elimination via 
the production of iNOS. Deficiency of this enzyme in mice promotes susceptibility 
to L. major infection [70]. The protective role of IFN-I was studied in vivo where 
neutralizing IFN-I in mice experimentally infected with L. major made them more 
vulnerable to infection and increase in parasite load due to enhanced parasite mul-
tiplication. Blocking IFN-I function led to dissolution of iNOS activity and reduced 
cytotoxicity at early stages of infection [71]. The stage of parasitic infection and the 
dose of IFN-I play a significant role in predicting the consequences of the disease 
[12, 37]. Mattner et al. [72] revealed that IFN-I acts in a dose-dependent manner, 
where a low dose against a high dose of IFN-I protected the L. major-infected 
BALB/c mice from progressive leishmaniasis. IFN-I treatment aids in IFN-γ produc-
tion via STAT4-dependent pathway [72].
6.5 IFN-II (IFN-γ)-associated immune changes in Leishmania infection
Leishmania immunity is mostly mediated by T lymphocytes and immune 
response is shown to be dependent on host genotype. This is evident from the 
fact that some inbred strains of mouse are susceptible, while others are resistant 
to Leishmania infection. In the human body, IFN-γ is not secreted alone, but 
other cytokines mainly IL-12, IL-10 and IL-4 influence the IFN-γ both at the 
level of induction and at the level of effector function. This further determines 
the course of infection [73, 74]. Several in vivo and in vitro experiments have 
shown that IFN-γ hinders the activation/expansion of CD4+ Th2 cells, resulting 
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Figure 3. 
Peripheral and thymic changes induced in host organism (mice or human) upon Leishmania infection.
in the preferential expression of Th1 immune response and Th1 immunity. IFN-γ 
expression pattern is well documented for correlation with protection against the 
parasitic diseases in old and new world Leishmania infection model. The absence 
of IFN-γ or IFN-γ receptor leads to expansion of Th2-type cellular response in 
C57BL/6 mice making the host highly vulnerable to L. major or L. amazonensis 
infection [75]. IFN-γ-mediated immune protection against Leishmania infection 
is also evident where CXCL10-treated, L. donovani-infected BALB/c mice display 
generation of perforins and granzyme B via CD8+ T-cell–dependent strong host-
protective Th1 response, accompanied by significant downregulation in Th2- and 
Treg-associated cytokines [76, 77]. Pretreatment of macrophages obtained from 
BALB/c, C57BL/6 and C3H/HeJ mice significantly reduces L. amazonensis load 
via an NO-mediated mechanism of IFN-γ production in the presence of recom-
binant CXCL10 [78]. Immune response against leishmaniasis is also dependent 
on Leishmania spp. involved in infection. Several comparative studies conducted 
with crude antigen extracts of L. braziliensis and L. amazonensis reported that 
the extracts of L. braziliensis are more potent over L. amazonensis in stimulating 
CXCL10 production correlating to IFN-γ-positivity and multi-functional CD4+ T 
cells in CL patients. Therefore, in agreement with the findings from murine infec-
tion models, CXCR3 and CXCL10 chemokines are also involved in protection and 
disease pathogenesis in leishmaniasis [79, 80]. Human VL is generally known to 
be predominated by Th2-type response. Anti-leishmanial drug treatments induce 
a significant Th1-type response in cured patients marked by the production of 
IFN-γ and IL-4 in the viscera. Contrary to VL, CL patients show a disease-healing 
response dominated by IFN-γ. IL-4, a Th2 cytokine, is rarely detected in CL cases 
[81]. In patients with active VL, the expression of IFN-γ is increased in the periph-
ery, but it may be possible that the effect is not enough to overcome the parasite 
multiplication or there is unresponsiveness to L. donovani antigen. This may be 
due to elevated level of immunosuppressive Th2-specific cytokines in active VL 
patients [82].
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6.6 Thymic alterations in Leishmania infection
Thymus is the least studied in context of Leishmania infection. A recent report 
demonstrates a decrease in thymic cellularity and concomitant thymic atrophy with 
severely compromised thymic microenvironment in a murine model co-conditioned 
with protein malnutrition and L. infantum infection. These mice exhibited a sig-
nificant reduction of the thymic corticomedullary ratio [83]. Similar studies done 
in our laboratory with L. donovani infected VL murine model demonstrate that the 
parasite homes to thymus and lead to expansion of medullary regions when compared 
to control uninfected mice (unpublished data). L. infantum infection in protein-
malnourished mice causes thymic atrophy due to a decrease of DP thymocytes and 
alters thymic chemotactic factors by diminishing CCL5, IGF1, CXCL9, 10 and 12 with 
significantly increased levels of IL-1α and IL-10 [83, 84]. It has been observed that due 
to Leishmania infection in mice, positively selected CD8+ or CD4+ T cells upregulate 
CCR7 and migrate to the medulla in response to CCL19/CCL21. CCR7 knockout mice 
were associated with cortical accumulation of SP thymocytes and decreased medullary 
CD4+SP and CD8+SP T cells. The migration of T cell is decreased in protein-malnour-
ished infected mice as the components of extracellular matrix and adhesion molecules 
are altered that compromise the migratory capabilities necessary for adequate lympho-
cyte proliferation, intrathymic maturation and extrathymic activation [85]. Peripheral 
and thymic changes associated with Leishmania infection are depicted in Figure 3.
7. Conclusions
In conclusion, the role of IFN family in both immune-protective and immune-
pathogenic processes in parasitic infections makes it a key set of molecules to be 
studied in depth (Figure 4). Modulatory effect of IFNs on T cells and downstream 
Figure 4. 
Mechanistic of IFNs (IFN-I and IFN-γ) upon parasitic invasion in host organism. IFNs play a dual role in 
disease progression and/or protection, depending on the type and expression levels in relation to other secretory 
molecules and cytokines (Th1/Th2/Treg) and cause-effect cross talk between different IFN producers and 
effector immune cells.
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effector function of T cells along with their complex cross-network functionality 
in other circulating blood and tissue-resident immune cells warrant further under-
standing on their role in disease manifestation and outcome. IFNs as the modulators 
of thymic structure and function are an interesting dimension of the immune-reg-
ulatory capabilities of these soluble immune molecules in infectious diseases. IFNs 
work as double-edged sword to modulate immune effector mechanisms determined 
by parasite and host components. This family of important cytokines can be 
tailored to be used as immunomodulators and/or immunotherapeutic molecules.
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